title: The multiple challenges in the management of a patient with HELLP syndrome, liver rupture and eclampsia.
abstract: We report a case of a patient with HELLP syndrome, hemorrhagic shock due to liver rupture and late postpartum eclampsia superimposed on lupus nephropathy and chronic hypertension. This patient was delivered at 26 weeks by C-section. Aggressive and complex surgical and medical treatments were necessary to achieve hemostasis and stabilize the patient. She recovered and was discharged to home on the 24th postpartum day in good condition. The premature baby was discharged home in fair condition on the 131st hospital day.
authors.affiliation: Dept. of Obstetrics and Gynecology, Charleston Area Medical Center, Charleston, USA.
authors.forename: Craig S
authors.initials: CS
authors.lastname: Herring
authors.forename: S Greg
authors.initials: SG
authors.lastname: Heywood
authors.forename: Christos G
authors.initials: CG
authors.lastname: Hatjis
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001803:Blood Transfusion / Q000379:methods; D002585:Cesarean Section / Q000379:methods; D003102:Colloids / Q000008:administration & dosage; D000077324:Crystalloid Solutions; D004461:Eclampsia / Q000188:drug therapy*; D005169:Factor VIII / Q000008:administration & dosage; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage; D017359:HELLP Syndrome / Q000188:drug therapy*; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007552:Isotonic Solutions / Q000008:administration & dosage; D008107:Liver Diseases / Q000150:complications / Q000473:pathology / Q000601:surgery*; D008278:Magnesium Sulfate / Q000008:administration & dosage; D011247:Pregnancy; D012422:Rupture, Spontaneous / Q000150:complications / Q000473:pathology; D012640:Seizures / Q000150:complications / Q000188:drug therapy; D015149:Tocolytic Agents / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D000959:Antihypertensive Agents; D003102:Colloids; D000077324:Crystalloid Solutions; D015718:Fibrin Tissue Adhesive; D007552:Isotonic Solutions; D015149:Tocolytic Agents; D006830:Hydralazine; D008278:Magnesium Sulfate; C078147:F8 protein, human; D005169:Factor VIII